Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Dusheiko

Showing results (41-50 of 115) with videos related to

Pageof 12
Sort By:
Antiviral Therapy|April 25, 2008
Ribavirin considerations in treatment optimizationGeoffrey Dusheiko, David Nelson, K Rajender Reddy
The New England Journal of Medicine|March 22, 2023
New Approaches to Chronic Hepatitis B. ReplyGeoffrey Dusheiko, Kosh Agarwal, Mala K Maini
Liver International : Official Journal of the International Association for the Study of the Liver|September 4, 2013
Forgotten, not neglected: viral hepatitis in resource-limited settings, recall for actionMaud Lemoine, Mark Thursz, Ramou Njie, et al.
Alimentary Pharmacology & Therapeutics|June 30, 2022
Review article: novel biomarkers in hepatitis B infectionJames Lok, Geoffrey Dusheiko, Ivana Carey, et al.
The Lancet. Gastroenterology & Hepatology|March 14, 2018
Authors' replyC Wendy Spearman, Mark W Sonderup, Geoffrey Dusheiko, et al.
Hepatology (Baltimore, Md.)|October 29, 2020
ReplyIvana Carey, Gavin Cloherty, Geoffrey Dusheiko, et al.
JHEP Reports : Innovation in Hepatology|January 13, 2023
Health inequalities in the management of chronic hepatitis B virus infection in patients from sub-Saharan Africa in high-income countriesTim Mitchell, Jeremy S Nayagam, Geoffrey Dusheiko, et al.
BMC Infectious Diseases|November 18, 2017
Effectiveness of current and future regimens for treating genotype 3 hepatitis C virus infection: a large-scale systematic reviewHosnieh Fathi, Andrew Clark, Nathan R Hill, et al.
Hepatology (Baltimore, Md.)|August 2, 2017
Hepatitis B cure: From discovery to regulatory approvalAnna S Lok, Fabien Zoulim, Geoffrey Dusheiko, et al.
Journal of Hepatology|December 10, 2021
Michael Charles Kew - Frontrunner in HepatologyChris Kassianides, Geoffrey Dusheiko, Adrian Di Bisceglie, et al.
Pageof 12

Showing results (41-50 of 115) with videos related to

Sort By:
Pageof 12
Antiviral Therapy|April 25, 2008
Ribavirin considerations in treatment optimizationGeoffrey Dusheiko, David Nelson, K Rajender Reddy
The New England Journal of Medicine|March 22, 2023
New Approaches to Chronic Hepatitis B. ReplyGeoffrey Dusheiko, Kosh Agarwal, Mala K Maini
Liver International : Official Journal of the International Association for the Study of the Liver|September 4, 2013
Forgotten, not neglected: viral hepatitis in resource-limited settings, recall for actionMaud Lemoine, Mark Thursz, Ramou Njie, et al.
Alimentary Pharmacology & Therapeutics|June 30, 2022
Review article: novel biomarkers in hepatitis B infectionJames Lok, Geoffrey Dusheiko, Ivana Carey, et al.
The Lancet. Gastroenterology & Hepatology|March 14, 2018
Authors' replyC Wendy Spearman, Mark W Sonderup, Geoffrey Dusheiko, et al.
Hepatology (Baltimore, Md.)|October 29, 2020
ReplyIvana Carey, Gavin Cloherty, Geoffrey Dusheiko, et al.
JHEP Reports : Innovation in Hepatology|January 13, 2023
Health inequalities in the management of chronic hepatitis B virus infection in patients from sub-Saharan Africa in high-income countriesTim Mitchell, Jeremy S Nayagam, Geoffrey Dusheiko, et al.
BMC Infectious Diseases|November 18, 2017
Effectiveness of current and future regimens for treating genotype 3 hepatitis C virus infection: a large-scale systematic reviewHosnieh Fathi, Andrew Clark, Nathan R Hill, et al.
Hepatology (Baltimore, Md.)|August 2, 2017
Hepatitis B cure: From discovery to regulatory approvalAnna S Lok, Fabien Zoulim, Geoffrey Dusheiko, et al.
Journal of Hepatology|December 10, 2021
Michael Charles Kew - Frontrunner in HepatologyChris Kassianides, Geoffrey Dusheiko, Adrian Di Bisceglie, et al.
Pageof 12